A Retroactive Single Institution Study of Three-Year Survival of HER-2/neu Positive Breast Cancer Treated with Adjuvant Chemotherapy, A Quality Improvement Project.

Authors

Deepika Kumar MS4, USF MCOM- LVHN Campus
Ramona E. Chase CRNP, Lehigh Valley Health NetworkFollow
Savitri Skandan MD, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

3-20-2017

Comments

Mentor: Ramona Chase & Savitri Skandan

Copyright © Lehigh Valley Health Network

Published In/Presented At

Kumar, D. Chase, R. E., Skandan, S. (2017, March). A Retroactive Single Institution Study of Three-Year Survival of HER-2/neu Positive Breast Cancer Treated with Adjuvant Chemotherapy, A Quality Improvement Project. Poster Presented at: 2017 SELECT Capstone Posters and Presentations Day. Kasych Family Pavilon, Lehigh Valley Health Network, Allentown, PA

Disciplines

Medical Education | Medicine and Health Sciences

Department(s)

USF-LVHN SELECT Program, USF-LVHN SELECT Program Faculty, USF-LVHN SELECT Program Students

Document Type

Poster